Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Recruiting at 1 trial location

Overseen By FirstFocus Study

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: Emory University

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

2120 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.

Research Team

Warren R Jones, PhD

Principal Investigator

Emory University

Eligibility Criteria

Inclusion Criteria

Infants between the chronological ages of 8-10 months;

Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision);

participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.

Treatment Details

Participant Groups

Group I: General Population Screening Cohort Experimental Treatment 1 Intervention

A general population cohort of 9-month-old infants presenting for well-child visits will be screened initially at 9 months of age, and then screened again sequentially at 12, 15, 18, 21, and 24 months, to test screening performance relative to outcome status with autism or developmental disabilities.

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials

1,735

Recruited

2,605,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials

3,007

Recruited

2,852,000+